iPhone | iPad
Android
Huawei
South Korea's Jeju Island was once used to exile convicts and prisoners
KT APPDOWNLOAD
AstraZeneca Covid-19 vaccine booster shot effective against Omicron: Oxford lab study
After a course of the vaccine, neutralising levels against Omicron were similar to those against the Delta variant.
Reuters file
A three-dose course of AstraZeneca's Covid-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from Covid-19.
After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus's Delta variant after two doses, the company added.
The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca.
More news from
'Modern Warfare 3' unveils its latest event, Vortex: Vi.Rus Mainframe, featuring a striking animated camo as its coveted reward
'Fortnite' insiders suggest that a significant feature inspired by 'Fall Guys' is on the horizon as part of a previously rumoured crossover event.
63-year-old Filipina patient endured varying degrees of discomfort and pain for years before coming to doctors on March 23
Construction to begin this year on state-of-the-art Thumbay Veterinary Hospital At Thumbay Medicity
Shashi Tharoor's World of Words is a weekly column dissecting English language
Between them the two players are set to receive a stake around $150 million from the Tour's newly-formed enterprise
The four-time Grand Slam winner has enjoyed huge success with her powerful baseline game but has struggled on clay
